Published in JAMA on August 08, 1980
Antibiotic induced meningitis. J Neurol Neurosurg Psychiatry (1994) 1.33
Ibuprofen: a severe systemic reaction. Can Med Assoc J (1983) 0.96
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost (2006) 16.11
Polyspecificity of monoclonal lupus autoantibodies produced by human-human hybridomas. N Engl J Med (1983) 4.43
Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome. Ann Rheum Dis (1996) 3.68
Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus (2003) 3.61
Idiotypic cross-reactions of monoclonal human lupus autoantibodies. J Exp Med (1983) 2.96
Rheumatology in Israel. Br J Rheumatol (1996) 2.66
Serum antibodies in epilepsy and seizure-associated disorders. Neurology (2005) 2.53
BCR-ABL transcripts in bone marrow aspirates of Philadelphia-negative essential thrombocytopenia patients: clinical presentation. Blood (1997) 2.35
Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders. Lancet (1998) 2.31
Production of autoantibodies by human-human hybridomas. J Clin Invest (1982) 2.22
Allergic vasculitis induced by hydrochlorothiazide: confirmation by mast cell degranulation test. Isr J Med Sci (1989) 2.11
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis (2010) 2.09
Characterization of biologically active antineutrophil cytoplasmic antibodies induced in mice. Pathogenetic role in experimental vasculitis. Arthritis Rheum (1995) 2.09
Anti-DNA antibody idiotypes in systemic lupus erythematosus. Lancet (1984) 2.08
Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) (2001) 2.02
Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation (1996) 1.92
Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype. Proc Natl Acad Sci U S A (1988) 1.91
Colchicine treatment for recurrent pericarditis. A decade of experience. Circulation (1998) 1.87
Native valve Staphylococcus epidermidis endocarditis: report of seven cases and review of the literature. Am J Med (1991) 1.85
Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc Natl Acad Sci U S A (1991) 1.77
Binding of cytoskeletal proteins by monoclonal anti-DNA lupus autoantibodies. Clin Immunol Immunopathol (1984) 1.76
Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut (2005) 1.73
European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis (2009) 1.69
All three receptors for vascular endothelial growth factor (VEGF) are expressed on B-chronic lymphocytic leukemia (CLL) cells. Leuk Res (2004) 1.65
Primary malignant neoplasms associated with chronic lymphocytic leukaemia. Postgrad Med J (1987) 1.65
No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus. J Rheumatol (1996) 1.58
Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging. Eur J Neurosci (2002) 1.57
Pharmacokinetics of 18F-labeled fluconazole in healthy human subjects by positron emission tomography. Antimicrob Agents Chemother (1993) 1.55
Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies. Ann Rheum Dis (2001) 1.55
Multiple serologic reactions and their relationship to clinical activity in systemic lupus erythematosus. Arthritis Rheum (1984) 1.53
Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Rheum Dis (2004) 1.53
Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Dis (2010) 1.52
Immunologic and genetic factors in autoimmune diseases. N Engl J Med (1984) 1.50
Elevated homocysteine levels in patients with Raynaud's syndrome. J Rheumatol (1999) 1.49
The prevalence of coeliac disease antibodies in patients with the antiphospholipid syndrome. Lupus (2003) 1.48
Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis (2003) 1.48
Detection of cross-reactive anti-DNA antibody idiotypes in the serum of systemic lupus erythematosus patients and of their relatives. Arthritis Rheum (1985) 1.48
Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity. Ann Rheum Dis (2005) 1.48
Autoimmune diseases and autoimmunity post-bone marrow transplantation. Bone Marrow Transplant (1998) 1.47
Generalized pustular drug eruptions: confirmation by in vitro tests. J Eur Acad Dermatol Venereol (1998) 1.45
Autoantibodies in neoplasia. An unresolved enigma. Cancer (1990) 1.45
Role of beta 2-glycoprotein I in the antiphospholipid antibody binding to endothelial cells. Lupus (1995) 1.44
The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome--molecular mimicry? J Rheumatol (2000) 1.44
Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome. Ann Rheum Dis (2005) 1.44
Transfer of experimental antiphospholipid syndrome by bone marrow cell transplantation. The importance of the T cell. Arthritis Rheum (1995) 1.44
The good, the bad and the ugly of vaccination. Isr Med Assoc J (2000) 1.43
Clinical characteristics of ruptured chordae tendineae in hospitalized patients: primary tear versus infective endocarditis. Clin Cardiol (1998) 1.42
A multidimensional autoantibody analysis specifying systemic lupus erythematosus patients with neuropsychiatric symptomatology. Isr J Med Sci (1992) 1.41
Low dose aspirin in patients with ischemic heart disease may precipitate secondary myocardial infarction. Isr J Med Sci (1996) 1.40
Superior vena cava occlusion in a patient with antiphospholipid antibody syndrome. J Rheumatol (1991) 1.40
Presence of a 16/6 related human anti-DNA common idiotype (SA1) in the anticardiolipin antibodies of patients with primary antiphospholipid syndrome. J Rheumatol (1991) 1.40
Listeria monocytogenes endocarditis in a patient with a prosthetic aortic valve. Isr J Med Sci (1993) 1.40
Expression of p53 in human leukemia and lymphoma. Blood (1986) 1.40
Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3). J Clin Invest (1992) 1.39
Post-traumatic meningococcemia in a patient with deficiency of the C7 complement component. Isr J Med Sci (1990) 1.39
Antiphospholipid antibody testing - slow progress? Int J Clin Pract (2012) 1.39
[Viagra--the first oral treatment for impotence that is not lacking in fatal effects]. Harefuah (1998) 1.38
Interferon-alpha-2b with VMCP for induction in multiple myeloma: the Israel Myeloma Cooperative Group experience. Isr J Med Sci (1995) 1.38
Effects of exposure to Finnish sauna. Isr J Med Sci (1976) 1.37
Mycobacteria and autoimmunity. Immunol Today (1988) 1.36
Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus. Rheumatology (Oxford) (2006) 1.35
A study of 20 SLE patients with intravenous immunoglobulin--clinical and serologic response. Lupus (1999) 1.31
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis (2008) 1.28
Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis. Atherosclerosis (1998) 1.26
The mosaic of autoimmunity. Immunol Today (1989) 1.23
Evaluation of the BioPlex 2200 ANA screen: analysis of 510 healthy subjects: incidence of natural/predictive autoantibodies. Ann N Y Acad Sci (2005) 1.22
Protein disulfide isomerase mediates integrin-dependent adhesion. FEBS Lett (2000) 1.21
Enhanced fatty streak formation in C57BL/6J mice by immunization with heat shock protein-65. Arterioscler Thromb Vasc Biol (1999) 1.21
Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes. Lupus (1999) 1.21
Induction of tissue factor-like activity in monocytes by anti-cardiolipin antibodies. J Immunol (1994) 1.19
Pulmonary nocardiosis complicating malignant lymphoma successfully treated with chemotherapy. Chest (1973) 1.18
Systemic lupus erythematosus one disease or many? Autoimmun Rev (2011) 1.18
Gaucher's disease: a disease with chronic stimulation of the immune system. Arch Pathol Lab Med (1982) 1.17
Anti-endothelial cell IgG antibodies from patients with Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion. Arthritis Rheum (1996) 1.17
Myopathy, lactic acidosis, and sideroblastic anemia: a new syndrome. Am J Med Genet (1995) 1.16
Metoclopramide and cardiac arrhythmia. Br Med J (1974) 1.16
Detection of antibodies to total histones and their subfractions in systemic lupus erythematosus patients and their asymptomatic relatives. Arthritis Rheum (1987) 1.16
Vitamin D: an instrumental factor in the anti-phospholipid syndrome by inhibition of tissue factor expression. Ann Rheum Dis (2010) 1.15
Prevalence of hypophosphatemia in sepsis and infection: the role of cytokines. Am J Med (1998) 1.14
What causes alopecia areata? Exp Dermatol (2013) 1.14
The dual association between lymphoma and autoimmunity. Blood Cells Mol Dis (2002) 1.14
Cutaneous involvement in erythroleukemia. Report of a case. Dermatologica (1974) 1.14
Cold-induced profuse sweating on back and chest. A new genetic entity? Lancet (1978) 1.14
Epstein-Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report. Ann N Y Acad Sci (2007) 1.14
Marked improvement of severe cardiac dysfunction after one course of intravenous immunoglobulin in a patient with systemic lupus erythematosus. Clin Rheumatol (1999) 1.13
Treatment of pregnant patients with antiphospholipid syndrome. Lupus (2003) 1.13
Antiphospholipid syndrome induced by HIV. Lupus (2001) 1.13
Prophylaxis of the antiphospholipid syndrome: a consensus report. Lupus (2003) 1.13
The sera of patients with Klebsiella infections contain a common anti-DNA idiotype (16/6) Id and anti-polynucleotide activity. Clin Exp Immunol (1987) 1.12
The role of anti-idiotypic antibodies in the induction of experimental systemic lupus erythematosus in mice. Eur J Immunol (1989) 1.10
Adjuvants and autoimmunity. Lupus (2009) 1.09
Serum immunoglobulin changes after accidental splenectomy in adults. Am J Surg (1978) 1.09
Immunolocalization of beta2-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques: potential implications for lesion progression. Circulation (1999) 1.08